*Billy Cadogan I. Introduction The United States began to spend significantly more on prescription drugs per capita compared to the rest of the world in the mid-1990s.[1] The increase in prices and the business practices within the prescription drug industry have gotten so out of hand that the Federal Trade Commission (FTC) filed a lawsuitContinue reading “High Prescription Drug Prices Are Slowly Gaining Attention From the Government. What is Being Done and Is It Enough?”
University of Baltimore Law Review 